Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Emily M. Wood"'
Publikováno v:
Diabetesmetabolic syndrome. 17(1)
Glucagon-like peptide1-receptor agonists (GLP1-RA) decrease major adverse cardiovascular events (MACE) in people with type 2 diabetes mellitus and cardiovascular disease (CVD). Caution is recommended for semaglutide and dulaglutide with risk of exace
Autor:
Katherine Norman, Karen E. Hemmings, Heba Shawer, Hollie L. Appleby, Alan J. Burnett, Nurasyikin Hamzah, Rajendra Gosain, Emily M. Woodhouse, David J. Beech, Richard Foster, Marc A. Bailey
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/4e92541fa5644dc5a9330d8337abb840
Autor:
Maura Agostini, Stephen O'Rahilly, Timothy M. Willson, David B. Savage, H. Eric Xu, Keith T. Garnes, John W.R. Schwabe, Odelia Rajanayagam, Aaron G. Smith, Mark Gurnell, V. Krishna K. Chatterjee, Emily M. Wood, Sidney H. Levinson
Publikováno v:
Endocrinology. 145:1527-1538
Loss-of-function mutations in the ligand-binding domain of human peroxisome proliferator-activated receptor gamma (PPARgamma) are associated with a novel syndrome characterized by partial lipodystrophy and severe insulin resistance. Here we have furt